Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

29.72
Delayed Data
As of 4:00pm ET
 +0.52 / +1.78%
Today’s Change
23.15
Today|||52-Week Range
34.50
+1.92%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close29.20
Today’s open28.44
Day’s range28.44 - 29.79
Volume19,253
Average volume (3 months)413,291
Market cap$1.6B
Data as of 4:00pm ET, 01/25/2022

Growth & Valuation

Earnings growth (last year)+11.85%
Earnings growth (this year)-42.80%
Earnings growth (next 5 years)-22.60%
Revenue growth (last year)+32.50%
P/E ratio19.7
Price/Sales2.60
Price/Book2.09

Competitors

----
VCELVericel Corp-0.07-0.21%
----
----
Data as of 4:00pm ET, 01/25/2022

Financials

Next reporting dateMarch 1, 2022
EPS forecast (this quarter)$0.26
Annual revenue (last year)$520.4M
Annual profit (last year)$127.0M
Net profit margin24.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
No executives to display
Corporate headquarters
Rockville, Maryland

Forecasts